Metabolic pathway-based subtypes associate glycan biosynthesis and treatment response in head and neck cancer.

Autor: Dankó B; Research Unit Translational Metabolic Oncology, Institute for Diabetes and Cancer, Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany.; Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer, ' Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany., Hess J; Research Unit Translational Metabolic Oncology, Institute for Diabetes and Cancer, Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany.; Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer, ' Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany.; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany., Unger K; Research Unit Translational Metabolic Oncology, Institute for Diabetes and Cancer, Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany.; Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer, ' Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany.; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.; Bavarian Cancer Research Center (BZKF), Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, German Cancer Research Center (DKFZ), Heidelberg, Germany., Samaga D; Research Unit Translational Metabolic Oncology, Institute for Diabetes and Cancer, Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany.; Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer, ' Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany., Walz C; Institute of Pathology, Faculty of Medicine, LMU Munich, Munich, Germany., Walch A; Research Unit Analytical Pathology, Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany., Sun N; Research Unit Analytical Pathology, Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany., Baumeister P; Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer, ' Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany.; Bavarian Cancer Research Center (BZKF), Munich, Germany.; Department of Otorhinolaryngology, Head and Neck Surgery, LMU University Hospital, LMU Munich, Munich, Germany.; Comprehensive Cancer Center, Munich, Germany., Zeng PYF; Department of Pathology and Laboratory Medicine, University of Western Ontario, London, ON, Canada.; Department of Otolaryngology - Head and Neck Surgery, University of Western Ontario, London, ON, Canada., Walter F; Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer, ' Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany.; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany., Marschner S; Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer, ' Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany.; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.; Comprehensive Cancer Center, Munich, Germany., Späth R; Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer, ' Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany.; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.; Comprehensive Cancer Center, Munich, Germany., Gires O; Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer, ' Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany.; Department of Otorhinolaryngology, Head and Neck Surgery, LMU University Hospital, LMU Munich, Munich, Germany., Herkommer T; Research Unit Translational Metabolic Oncology, Institute for Diabetes and Cancer, Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany.; Institute of Pathology, Faculty of Medicine, LMU Munich, Munich, Germany., Dazeh R; Research Unit Translational Metabolic Oncology, Institute for Diabetes and Cancer, Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany.; Institute of Pathology, Faculty of Medicine, LMU Munich, Munich, Germany., Matos T; Research Unit Translational Metabolic Oncology, Institute for Diabetes and Cancer, Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany.; Institute of Pathology, Faculty of Medicine, LMU Munich, Munich, Germany., Kreutzer L; Research Unit Translational Metabolic Oncology, Institute for Diabetes and Cancer, Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany.; Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer, ' Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany., Matschke J; Institute of Cell Biology (Cancer Research), University Hospital Essen, University of Duisburg-Essen, Essen, Germany.; German Cancer Consortium (DKTK) partner site Essen a partnership between DKFZ and University Hospital, Essen, Germany., Eul K; Institute of Cell Biology (Cancer Research), University Hospital Essen, University of Duisburg-Essen, Essen, Germany., Klauschen F; Bavarian Cancer Research Center (BZKF), Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Institute of Pathology, Faculty of Medicine, LMU Munich, Munich, Germany.; Comprehensive Cancer Center, Munich, Germany., Pflugradt U; Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer, ' Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany.; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.; Comprehensive Cancer Center, Munich, Germany., Canis M; Department of Otorhinolaryngology, Head and Neck Surgery, LMU University Hospital, LMU Munich, Munich, Germany.; Comprehensive Cancer Center, Munich, Germany., Ganswindt U; Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer, ' Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany.; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.; Department of Radiation Oncology, Innsbruck Medical University, Innsbruck, Austria.; Comprehensive Cancer Center Innsbruck, Innsbruck, Austria., Mymryk JS; Department of Otolaryngology - Head and Neck Surgery, University of Western Ontario, London, ON, Canada.; Department of Microbiology & Immunology, University of Western Ontario, London, ON, Canada.; Department of Oncology, University of Western Ontario, London, ON, Canada., Wollenberg B; Comprehensive Cancer Center, Munich, Germany.; Clinic of Otorhinolaryngology, Klinikum rechts der Isar, Technical University Munich, Munich, Germany.; Department of Otorhinolaryngology, University of Luebeck, Luebeck, Germany., Nichols AC; Department of Pathology and Laboratory Medicine, University of Western Ontario, London, ON, Canada.; Department of Otolaryngology - Head and Neck Surgery, University of Western Ontario, London, ON, Canada.; Department of Oncology, University of Western Ontario, London, ON, Canada., Belka C; Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer, ' Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany.; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.; Bavarian Cancer Research Center (BZKF), Munich, Germany.; German Cancer Consortium (DKTK), Partner Site Munich, German Cancer Research Center (DKFZ), Heidelberg, Germany.; Comprehensive Cancer Center, Munich, Germany., Zitzelsberger H; Research Unit Translational Metabolic Oncology, Institute for Diabetes and Cancer, Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany.; Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer, ' Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany.; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany., Lauber K; Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer, ' Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany.; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.; Comprehensive Cancer Center, Munich, Germany., Selmansberger M; Research Unit Translational Metabolic Oncology, Institute for Diabetes and Cancer, Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany. martin.selmansberger@helmholtz-munich.de.; Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer, ' Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH), Neuherberg, Germany. martin.selmansberger@helmholtz-munich.de.

Publikováno v: NPJ precision oncology [NPJ Precis Oncol] 2024 May 23; Vol. 8 (1), pp. 116. Date of Electronic Publication: 2024 May 23.

CLIP2 as radiation biomarker in papillary thyroid carcinoma.

Autor: Selmansberger, M¹, Feuchtinger, A², Zurnadzhy, L³, Michna, A¹, Kaiser, J C⁴, Abend, M⁵, Brenner, A⁶, Bogdanova, T³, Walch, A², Unger, K¹, Zitzelsberger, H¹, Hess, J¹

Publikováno v: Oncogene. 7/23/2015, Vol. 34 Issue 30, p3917-3925. 9p. 2 Color Photographs, 1 Black and White Photograph, 2 Diagrams, 2 Charts, 1 Graph.

Transcriptomic landscape of radiation-induced murine thyroid proliferative lesions.

Autor: Stauffer E; Helmholtz Zentrum München - German Research Center for Environmental Health, Research Unit Radiation Cytogenetics, Neuherberg, Germany., Weber P; Helmholtz Zentrum München - German Research Center for Environmental Health, Research Unit Radiation Cytogenetics, Neuherberg, Germany., Heider T; Helmholtz Zentrum München - German Research Center for Environmental Health, Research Unit Radiation Cytogenetics, Neuherberg, Germany., Dalke C; Helmholtz Zentrum München - German Research Center for Environmental Health, Institute of Metabolism and Cell Death, Neuherberg, Germany., Blutke A; Helmholtz Zentrum München - German Research Center for Environmental Health, Research Unit Analytical Pathology, Neuherberg, Germany., Walch A; Helmholtz Zentrum München - German Research Center for Environmental Health, Research Unit Analytical Pathology, Neuherberg, Germany., Burgstaller G; Helmholtz Zentrum München - Institute of Lung Biology and Disease (ILBD) and Comprehensive Pneumology Center (CPC), Member of the German Center for Lung Research (DZL), Munich, Germany., Brix N; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany., Lauber K; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.; Helmholtz Zentrum München - German Research Center for Environmental Health GmbH, Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer', Neuherberg, Germany., Zitzelsberger H; Helmholtz Zentrum München - German Research Center for Environmental Health, Research Unit Radiation Cytogenetics, Neuherberg, Germany.; Helmholtz Zentrum München - German Research Center for Environmental Health GmbH, Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer', Neuherberg, Germany., Unger K; Helmholtz Zentrum München - German Research Center for Environmental Health, Research Unit Radiation Cytogenetics, Neuherberg, Germany.; Department of Radiation Oncology, University Hospital, LMU Munich, Munich, Germany.; Helmholtz Zentrum München - German Research Center for Environmental Health GmbH, Clinical Cooperation Group 'Personalized Radiotherapy in Head and Neck Cancer', Neuherberg, Germany., Selmansberger M; Helmholtz Zentrum München - German Research Center for Environmental Health, Research Unit Radiation Cytogenetics, Neuherberg, Germany.

Publikováno v: Endocrine-related cancer [Endocr Relat Cancer] 2021 Mar; Vol. 28 (3), pp. 213-224.

Untersuchungen zur Prävalenz, Dosisabhängigkeit und Funktion des CLIP2 Strahlenmarkers und molekulargenetische Klassifizierung strahleninduzierter papillärer Schilddrüsenkarzinome

Autor: Selmansberger, M.

Publikováno v: Diss., 2015, 68 S.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3474::6f20f0b1b18a31670c28f7e67054c78f
https://push-zb.helmholtz-muenchen.de/frontdoor.php?source_opus=49612

Mechanistic Insights on Metformin and Arginine Implementation as Repurposed Drugs in Glioblastoma Treatment.

Autor: Barciszewska, Anna-Maria^1,2 (AUTHOR) ambarciszewska@ump.edu.pl, Belter, Agnieszka³ (AUTHOR) abelter@ibch.poznan.pl, Barciszewski, Jakub F.³ (AUTHOR) jbarciszewski@ibch.poznan.pl, Gawrońska, Iwona³ (AUTHOR) iwonag@ibch.poznan.pl, Giel-Pietraszuk, Małgorzata³ (AUTHOR) giel@ibch.poznan.pl, Naskręt-Barciszewska, Mirosława Z.³ (AUTHOR) mbarcisz@ibch.poznan.pl

Publikováno v: International Journal of Molecular Sciences. Sep2024, Vol. 25 Issue 17, p9460. 15p.